Impact on patient outcomes of spondyloarthritis-inflammatory bowel disease multi-disciplinary meetings.
Autor: | Sayers S; Rheumatology Research Unit, Department of Medicine, University of Cambridge, Cambridge, UK., Lam D; Department of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Shah Q; Rheumatology Research Unit, Department of Medicine, University of Cambridge, Cambridge, UK., Evans J; Addenbrooke's Hospital, Hills Road, Rheumatology, CB2 2QQ, Cambridge., Parkes M; Department of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Stober C; Department of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Rimmer J; Department of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Clunie G; Department of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Gudu TE; Department of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Rosembert D; Department of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Subramanian S; Department of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Brookes-Jones S; Department of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Moss S; Department of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Raine T; Department of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Jadon D; Rheumatology Research Unit, Department of Medicine, University of Cambridge, Cambridge, UK. |
---|---|
Jazyk: | angličtina |
Zdroj: | Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Feb 23. Date of Electronic Publication: 2024 Feb 23. |
DOI: | 10.1093/rheumatology/keae116 |
Abstrakt: | Objectives: To assess the impact on patient outcomes of the spondyloarthritis (SpA) and inflammatory bowel disease (IBD) multidisciplinary team (MDT) meetings in a large university hospital. Methods: A single-centre retrospective observational case-note review was conducted assessing the outcome of all 226 cases discussed at the SpA-IBD MDT meetings in a large UK university hospital between 2017-2022. Results: A total of 226 patients were discussed. It was deemed that 97% of MDT meetings helped to improve communication between teams, and 100% were educational. A total of 57% of discussions led to an instant change of disease management, while 40% of discussions resulted in a treatment plan that avoided the use of dual advanced therapy. This improved patient safety by reducing immunosuppression. The MDT meetings were highly cost and time efficient; 125 referrals between specialists were avoided, and in 51 cases there was a significant chance of reducing future drug costs. A timely investigation or appointment was arranged following 50% of MDT discussions, helping to clarify the diagnosis and optimise patient care. 9% of meetings enabled drugs to be prescribed to patients that are not yet licenced for the other speciality, thereby improving treatment options available in the management of complex cases. Conclusion: The MDT meetings have been beneficial for patients, the clinical team and the institution. This approach might be considered by other rheumatology and gastroenterology departments. (© The Author(s) 2024. Published by Oxford University Press on behalf of the British Society for Rheumatology.) |
Databáze: | MEDLINE |
Externí odkaz: |